Causal relationships between cerebrospinal fluid metabolites, immune cell traits, and head and neck cancers

Emerging evidence suggests that cerebrospinal fluid (CSF) metabolites may serve as valuable biomarkers in head and neck cancers (HNCs). However, their causal relationships and potential mechanisms remain underexplored. We conducted a bidirectional Mendelian randomization (MR) study to evaluate causal relationships between genetically predicted CSF metabolites, immune cell traits (ICTs), and HNC risk. Summary-level data were obtained from large-scale genome-wide association studies (GWAS), including 388 CSF metabolites (n = 291), 731 ICTs (n = 3,757), and HNCs (n = 373,122). Bidirectional MR was employed to investigate causal associations, with mediation analysis applied to assess the potential mediating role of ICTs. A series of sensitivity analyses were conducted to address heterogeneity and pleiotropy concerns. Forward MR identified nine CSF metabolites with causal associations: elevated citrulline and adenine correlated with reduced HNC risk, whereas hypoxanthine, N-acetylglutamate, N-acetylleucine, nicotinamide riboside, and X-24,813 conferred elevated risk. Dimethyl sulfone exhibited marginal protective effects. Reverse MR revealed tumor genetic susceptibility inversely modulated 12 metabolites, including pyroglutamine, 1-arachidonoyl-gpc (20:4n6), 3-hydroxy-2-ethylpropionate, 3-hydroxyoctanoate, 3-ureidopropionate, 7-methylguanine, adenine, guanosine, N2, and N2-dimethylguanosine, while elevating 2-aminophenol sulfate and N6-methyllysin. Mediation analyses suggested that CD45 on CD33br HLA DR + CD14dim and CD80 on granulocytes may potentially mediate the metabolite-HNC interactions. This study identifies bidirectional relationships between CSF metabolites and HNC risk and nominates ICTs as possible mediators. These findings implicate CSF metabolites in HNC pathogenesis and highlight their potential as diagnostic biomarkers and therapeutic targets, warranting experimental validation and clinical investigation.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2025-12-05
DOI
https://doi.org/10.1007/s12672-025-04213-4
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Causal relationships between cerebrospinal fluid metabolites, immune cell traits, and head and neck cancers

Xueyao Cai, Zhizhao Chen, Fan Liu, Li Gan
Discover Oncology
Head and Neck Cancer Studies
article

Causal relationships between cerebrospinal fluid metabolites, immune cell traits, and head and neck cancers

Xueyao Cai, Zhizhao Chen, Fan Liu, Li Gan
article en

Abstract

Emerging evidence suggests that cerebrospinal fluid (CSF) metabolites may serve as valuable biomarkers in head and neck cancers (HNCs). However, their causal relationships and potential mechanisms remain underexplored. We conducted a bidirectional Mendelian randomization (MR) study to evaluate causal relationships between genetically predicted CSF metabolites, immune cell traits (ICTs), and HNC risk. Summary-level data were obtained from large-scale genome-wide association studies (GWAS), including 388 CSF metabolites (n = 291), 731 ICTs (n = 3,757), and HNCs (n = 373,122). Bidirectional MR was employed to investigate causal associations, with mediation analysis applied to assess the potential mediating role of ICTs. A series of sensitivity analyses were conducted to address heterogeneity and pleiotropy concerns. Forward MR identified nine CSF metabolites with causal associations: elevated citrulline and adenine correlated with reduced HNC risk, whereas hypoxanthine, N-acetylglutamate, N-acetylleucine, nicotinamide riboside, and X-24,813 conferred elevated risk. Dimethyl sulfone exhibited marginal protective effects. Reverse MR revealed tumor genetic susceptibility inversely modulated 12 metabolites, including pyroglutamine, 1-arachidonoyl-gpc (20:4n6), 3-hydroxy-2-ethylpropionate, 3-hydroxyoctanoate, 3-ureidopropionate, 7-methylguanine, adenine, guanosine, N2, and N2-dimethylguanosine, while elevating 2-aminophenol sulfate and N6-methyllysin. Mediation analyses suggested that CD45 on CD33br HLA DR + CD14dim and CD80 on granulocytes may potentially mediate the metabolite-HNC interactions. This study identifies bidirectional relationships between CSF metabolites and HNC risk and nominates ICTs as possible mediators. These findings implicate CSF metabolites in HNC pathogenesis and highlight their potential as diagnostic biomarkers and therapeutic targets, warranting experimental validation and clinical investigation.

Discover OncologyVol. 17(1)
Central South University (CN), Guangdong Industry Technical College (CN), Key Laboratory of Guangdong Province (CN), Third Xiangya Hospital (CN)
Openalex Percentile: Top 47%
Head and Neck Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.